These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 7485950)

  • 21. Change from propylthiouracil to carbimazole proves fatal.
    Burt MG; Conaglen JV
    N Z Med J; 2001 Dec; 114(1145):553. PubMed ID: 11833950
    [No Abstract]   [Full Text] [Related]  

  • 22. Rapid neutrophil recovery from acquired agranulocytosis by recombinant human granulocyte-macrophage colony-stimulating factor in an intensive care patient.
    Weiss M; Gross-Weege W; Wernet P
    Crit Care Med; 1992 Oct; 20(10):1490-1. PubMed ID: 1395674
    [No Abstract]   [Full Text] [Related]  

  • 23. Pseudomonas aeruginosa ecthyma gangrenosum and facial cellulitis complicating carbimazole-induced agranulocytosis.
    del Giudice P; Cua E; Bernard E; Chichmanian RM; Oregionni O; Brucker F; Dellamonica P
    Arch Dermatol; 2006 Dec; 142(12):1663-4. PubMed ID: 17179011
    [No Abstract]   [Full Text] [Related]  

  • 24. [A serious adverse effect: sepsis due to carbimazole].
    Guardiola PD; Tenreiro AP
    Endocrinol Nutr; 2009; 56(7):378-80. PubMed ID: 19883898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Granulocyte-macrophage colony stimulating factor for the treatment of drug induced agranulocytosis.
    Nand S; Bayer R; Prinz RA; Felten W; Godwin JE
    Am J Hematol; 1991 Aug; 37(4):267-9. PubMed ID: 1858785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changing drugs--only when necessary.
    N Z Med J; 2001 Dec; 114(1145):536. PubMed ID: 11833944
    [No Abstract]   [Full Text] [Related]  

  • 27. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole.
    Vilchez FJ; Torres I; Garcia-Valero A; López-Tinoco C; de Los Santos A; Aguilar-Diosdado M
    Ann Pharmacother; 2006 Nov; 40(11):2059-63. PubMed ID: 17077174
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical presentation and management of drug-induced agranulocytosis.
    Andrès E; Zimmer J; Mecili M; Weitten T; Alt M; Maloisel F
    Expert Rev Hematol; 2011 Apr; 4(2):143-51. PubMed ID: 21495924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of haematopoietic growth factors granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor in the management of drug-induced agranulocytosis.
    Andrès E; Maloisel F; Zimmer J
    Br J Haematol; 2010 Jul; 150(1):3-8. PubMed ID: 20151980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antithyroid drug-induced agranulocytosis: clinical experience with ten patients treated at one institution and review of the literature.
    Meyer-Gessner M; Benker G; Lederbogen S; Olbricht T; Reinwein D
    J Endocrinol Invest; 1994 Jan; 17(1):29-36. PubMed ID: 7516356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Choanal atresia: the result of maternal thyrotoxicosis or fetal carbimazole?
    Barwell J; Fox GF; Round J; Berg J
    Am J Med Genet; 2002 Jul; 111(1):55-6; discussion 54. PubMed ID: 12124735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Antithyroid agents related agranulocytosis: Literature review].
    Andrès E; Weitten T; Mourot-Cottet R; Keller O; Zulfiqar AA; Serraj K; Vogel T; Tebacher M
    Rev Med Interne; 2016 Aug; 37(8):544-50. PubMed ID: 27241077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A 40-year-old woman who developed jaundice during therapy for thyrotoxicosis.
    Ekpebegh CO; Levitt NS
    PLoS Med; 2006 Jan; 3(1):e12. PubMed ID: 16435888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Retrospective analysis of 18 cases with agranulocytosis induced by antithyroid drugs].
    Dai W; Zhang J; Zhan Z; Xu B; Jin H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1998 Jun; 20(3):226-9. PubMed ID: 11367711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clozapine-induced agranulocytosis].
    Valevski A; Modai I; Weizman A
    Harefuah; 1994 Jan; 126(1):32-5. PubMed ID: 7511125
    [No Abstract]   [Full Text] [Related]  

  • 36. Antithyroid drug-induced agranulocytosis: how has granulocyte colony-stimulating factor changed therapy?
    Tajiri J; Noguchi S
    Thyroid; 2005 Mar; 15(3):292-7. PubMed ID: 15785251
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sulfasalazine induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
    Kuipers EJ; Vellenga E; de Wolf JT; Hazenberg BP
    J Rheumatol; 1992 Apr; 19(4):621-2. PubMed ID: 1350640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced agranulocytosis treated with granulocyte-macrophage colony stimulating factor.
    Hurtado R; Candelaria M; Majluf-Cruz A; Sosa-Camas RE; Labardini-Méndez J
    Rev Invest Clin; 1994; 46(1):59-61. PubMed ID: 8079066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Haematopoietic growth factors in chloramphenicol-induced agranulocytosis.
    Chawla AK; Laiq SM
    J Assoc Physicians India; 2002 May; 50(5):742. PubMed ID: 12186144
    [No Abstract]   [Full Text] [Related]  

  • 40. Granulocyte-Colony Stimulating Factor (G-CSF) Therapy in Antithyroid Drug-induced Agranulocytosis.
    Andrès E; Maloisel F
    Endocr J; 2005 Jun; 52(3):383. PubMed ID: 16006735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.